Challenges in Managing Adverse Events and Unmet Needs in Leukemia
Dr McCloskey highlights challenges in adverse event management and discusses unmet needs in the treatment of patients with leukemia.
Stay updated with breaking news from Leukemia Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr McCloskey highlights challenges in adverse event management and discusses unmet needs in the treatment of patients with leukemia.
James K. McCloskey, MD, a specialist in leukemia, discusses how the treatment landscape has changed in recent years.
Following ASH 2023, a hematologist-oncologist discusses recent updates on approved and emerging therapies for patients with leukemia, highlighting the TRANSFORM-1 trial looking at navitoclax plus ruxolitinib.
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it...
Press release content from Accesswire. The AP news staff was not involved in its creation.